
Tool is an example of integrating AI in clinical trials

Seizing opportunities in a changing medicines landscape

CVMP recommends Hepizovac for approval

PRAC carried out its responsibilities for managing risks associated with medicine use

Patients invited to report suspicious offers

Patients can now locate and enrol in trials in their area
Find medicine
What's new
FAQs
Latest news

Manufacturers can request advice on their medical device clinical development programme

Artificial intelligence tool reliably identifies disease severity and reduces variability

Seizing opportunities in a changing medicines landscape
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting

The vaccine will protect cattle from outbreaks, protect animal health and prevent economic losses

EMA annual report 2024 and network strategy to 2028 adopted
Events
EudraVigilance is the EU's system for managing and analysing information on adverse reactions to medicines which have been authorised or are being studied in clinical trials in the European Economic Area (EEA) and supports the reporting and analysis of suspected adverse reactions originating from clinical trials and the post-authorisation phase of...
This meeting brings together the members of the Patients and Consumers Working Party (PCWP) and the Healthcare Professionals Working Party (HCPWP).